Table 4.
Phase | Chemotherapy Agents | Schedule |
---|---|---|
Induction (28 days) | Dexamethasone PO | Days 1–5, 15–19 |
Vincristine IV | Days 3, 10, 17, 24 | |
Mitoxantrone IV | Days 1, 2 | |
Pegaspargase IM/IV | Days 3, 18 | |
Methotrexate IT | Days 1, 8 (also Days 15, 22 for CNS3) | |
Consolidation (28 days) | Dexamethasone PO | Days 1–5 |
Vincristine IV | Day 3 | |
Methotrexate IV | Day 8 | |
Pegaspargase IM/IV | Day 9 | |
Cyclophosphamide IV | Days 15–19 | |
Etoposide IV | Days 15–19 | |
Methotrexate IT | Day 8 | |
Intensification (28 days) | Dexamethasone PO | Days 1–5 |
Vincristine IV | Day 3 | |
Cytarabine IV, every 12 hours | Days 1, 2, 8, 9 | |
Erwinia ASP IM | Days 2, 4, 9, 11, 23 | |
Methotrexate IV | Day 22 | |
Methotrexate IT | Days 1, 22 | |
Before SCT | Fludarabine IV | Days 1–5 |
Cytarabine IV | Days 1–5 | |
Liposomal Daunorubicin IV | Day 1 | |
Before Maintenancea (weeks 14–29) | Dexamethasone PO | Days 1–5, 57–61 |
Vincristine IV | Days 3, 59 | |
6-mercaptopurine PO | Days 1–42, 57–98 | |
Methotrexate PO | Days 10, 17, 31, 38, 67, 74, 88, 95 | |
Etoposide IV | Days 42, 49, 99, 106 | |
Cyclophosphamide IV | Days 42, 49, 99, 106 | |
Cytarabine IV | Days 43–46, 50–53, 100–103, 107–110 | |
Methotrexate IT | Days 1, 43, 57, 99 | |
Maintenancea (4-week cycles from weeks 30–104) | Dexamethasone PO | Days 1–5 |
Mercaptopurine PO | Days 1–28 | |
Methotrexate PO | Weekly | |
Vincristine IV | Day 1 | |
Methotrexate IT | Day 1 |
Note: aPhase given to patients who did not go to SCT.
Abbreviations: PO, oral; IV, intravenous; IM, intramuscular; IT, intrathecal; CNS, central nervous system; SCT, stem cell transplant; ASP, asparaginase.